Product Name | MF | CAS | Details |
---|
5-(Aminomethyl)thiophene-2-sulfonamide | C5H8N2O2S2 | 408352-66-9 | Details |
C15ORF24 Blocking Peptide | Details |
CDK6 antibody (Tyr13) | Details |
2-({[(4-Chlorophenyl)methyl]carbamoyl}amino)acetic acid | C10H11ClN2O3 | 1016730-04-3 | Details |
1-(3-Chlorophenyl)cyclobutan-1-amine hydrochloride | C10H13Cl2N | 959140-89-7 | Details |
1-(5-Bromo-2-methylphenyl)ethan-1-amine | C9H12BrN | 1270541-79-1 | Details |
6-Chloro-5-methoxypyridine-3-carbaldehyde | C7H6ClNO2 | 1060801-67-3 | Details |
5-(2-Aminoethyl)-4-(propan-2-yl)-4H-1,2,4-triazole-3-thiol hydrochloride | C7H15ClN4S | 1258652-25-3 | Details |
5-(Carbamoylmethyl)thiophene-2-sulfonyl chloride | C6H6ClNO3S2 | 1479499-40-5 | Details |
Rat Free Thyroxine ELISA kit | Details |
RPL39 antibody | Details |
VASP Blocking Peptide | Details |
2-Chloro-2',3'-O-isopropylideneadenosine | C13H16ClN5O4 | 24639-06-3 | Details |
3-bromo-1H-pyrrole-2-carbaldehyde | C5H4BrNO | 408359-07-9 | Details |
tert-Butyl N-(1-cyclopentyl-3-hydroxypropan-2-yl)carbamate | C13H25NO3 | 1454913-95-1 | Details |
3-Fluoro-4-methylphenol | C7H7FO | 452-78-8 | Details |
3-Methyl-3-azabicyclo[3.1.1]heptan-6-one hydrochloride, somers | C7H12ClNO | 1375474-60-4 | Details |
CTRL antibody | Details |
5-(4-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde | C11H8FNO | 2827733-28-6 | Details |
CEP 1347 | C33H33N3O5S2 | 156177-65-0 | Details |
H-HHGSDHERNYIY-OH | Details |
Methyl 3-aminophenylacetate hydrochloride | C9H12ClNO2 | 150319-83-8 | Details |
Taxuspine W | C26H36O9 | 181309-92-2 | Details |
4-Bromo-1-hydroxyanthraquinone-2-carboxylic acid | C15H7BrO5 | 320576-21-4 | Details |
Monkey IgA ELISA Kit | Details |
2-Methylaminoethanol | C3H9NO | 109-83-1 | Details |
Teclistamab | 2119595-80-9 | Details |
Isostearylalcohol | C18H38O | 27458-93-1 | Details |
(E)-1-Fluoro-2-(2-nitrovinyl)benzene | C8H6FNO2 | 192818-72-7 | Details |
Naphthol AS-BI, 94.0% | C18H14BrNO3 | 1237-75-8 | Details |
2-(Oxolan-2-yl)pyrrolidine | C8H15NO | 383127-91-1 | Details |
cis-Resveratrol | C14H12O3 | 61434-67-1 | Details |
N-Nitroso-N-methylaniline | C7H8N2O | 614-00-6 | Details |
Glycyl-glycyl-glycIne | C6H11N3O4 | 556-33-2 | Details |
a,a-D-Trehalose dihydrate | C12H22O11·2H2O | 6138-23-4 | Details |
Heliosupine N-oxide | C20H31NO8 | 31701-88-9 | Details |
H-NIEFFTKNSAFPKTT-OH | Details |
2-Butyl-5-nitrobenzofuran | C12H13NO3 | 133238-87-6 | Details |
N-Acetyl-a-D-glucosamine-1-phosphate disodium salt | C8H17NNaO9P | 31281-59-1 | Details |
2-Bromo-1,3,4,5,6,7,8-heptafluoronaphthalene | C10BrF7 | 27041-17-4 | Details |
FITC-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH (Contains FITC isomer I) | C62H67N11O20S | 1926163-32-7 | Details |
(4-Hydroxyphenyl)acetone | C9H10O2 | 770-39-8 | Details |
Methyl 2-ethyl-5-nitrobenzoate | C10H11NO4 | 103205-48-7 | Details |
Tulathromycin B - 95% | C41H79N3O12 | 280755-12-6 | Details |
H-MAMA-OH | Details |
H-IPRRIRQGF-OH | Details |
AquaSpark??alpha-L-idopyranosiduronic acid, Ramot at Tel-Aviv University Ltd. Patent family WO 2017/130191 | Details |
5-[4-(Trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-amine | C9H6F3N3S | 10445-04-2 | Details |
(2-bromo-5-fluorophenyl)hydrazine | C6H6BrFN2 | 776239-07-7 | Details |
Clioquinol - Bio-X ? | C9H5ClINO | 130-26-7 | Details |
Tazarotene | C21H21NO2S | 118292-40-3 | Details |
ZNF134 antibody | Details |
SIVmac239 - 30 | C64H112N22O22S | Details |
LGALS3 Blocking Peptide | Details |
1H-Indazole-3-carboxylic acid | C8H6N2O2 | 4498-67-3 | Details |
5-Ethyl-4-(methoxycarbonyl)-3-methyl-1H-pyrrole-2-carboxylic acid | C10H13NO4 | 104303-50-6 | Details |
Quercetin-3-O-D-glucosyl]-(1-2)-L-rhamnoside | C27H30O16 | 143016-74-4 | Details |
5,6-Diamino-1-methyluracil | C5H8N4O2 | 6972-82-3 | Details |
Poly(vinyl chloride-co-vinyl acetate-co-vinyl alcohol) | C8H13ClO3 | 25086-48-0 | Details |
Bacoside A3 | C47H76O18 | 157408-08-7 | Details |
4-Oxo-3,4-dihydro-2H-1-benzopyran-6-sulfonamide | C9H9NO4S | 955903-90-9 | Details |
N-Tosyl-L-alanine 3-indoxyl ester | C18H18N2O4S | 75062-54-3 | Details |
Bicyclo[3.2.0]heptane-6-carboxylic acid | C8H12O2 | 1824197-32-1 | Details |
4-(Aminomethyl)-1-methyl-1H-pyrazol-5-amine | C5H10N4 | 753444-70-1 | Details |
2-Bromo-3,4-difluorophenylacetonitrile | C8H4BrF2N | 1781212-27-8 | Details |
12-Doxyl stearic acid | C22H42NO4* | 29545-47-9 | Details |
1-Methylnaphthalene-2-carboxylic acid | C12H10O2 | 4488-44-2 | Details |
2-(5-Oxooxolan-2-yl)acetic acid | C6H8O4 | 60551-20-4 | Details |
2-(8-Heptadecenyl)-4,6-dihydroxybenzoic acid | C24H38O4 | 69506-65-6 | Details |
2-Amino-6-chloropyridine-4-carboxylic acid | C6H5ClN2O2 | 6313-55-9 | Details |
3-Acetyl-N-(prop-2-en-1-yl)benzene-1-sulfonamide | C11H13NO3S | 796083-76-6 | Details |
3-(2,4-Dimethylphenyl)-1-phenyl-1H-pyrazole-4-carboxylic acid | C18H16N2O2 | 956386-17-7 | Details |
methyl 5-((3-(2-chlorophenyl)-5-methylisoxazol-4-yl)carbonylamino)-3-(methoxycarbonyl)benzoate | C21H17ClN2O6 | 310452-97-2 | Details |
Epipolygodial | C15H22O2 | 5956-39-8 | Details |
2,6-Dioxopiperidine-4-carboxylic acid | C6H7NO4 | 6973-55-3 | Details |
5-Acetyl-2-methylfuran-3-carboxylic acid | C8H8O4 | 1211585-73-7 | Details |
1,3-Dioxaindane-4-sulfonyl chloride | C7H5ClO4S | 87473-88-9 | Details |
2-Acetamido-6-O-(a-2-N-acetylneuraminyl)-2-deoxy-a-D-galactopyranosyl serine | C22H37N3O16 | 114661-01-7 | Details |
IGFBP4 Blocking Peptide | Details |
5-Oxa-8-azaspiro[2.6]nonane | C7H13NO | 220687-59-2 | Details |
N-(2-Amino-phenyl)-nicotinamide | C12H11N3O | 436089-31-5 | Details |
1-(Trifluoromethyl)cycloheptan-1-ol | C8H13F3O | 1248683-84-2 | Details |
Cyclohexylbutanoyl-N-hydroxyethylglucamide | C18H35NO7 | 864434-15-1 | Details |
beta-Amyloid (12-28) – Cys | C92H140N26O26S | Details |
3-Amino-4-chloro-N-(3-chloro-4-methylphenyl)benzene-1-sulfonamide | C13H12Cl2N2O2S | 78726-73-5 | Details |
2-[7-(Benzyloxy)-1H-indol-3-yl]ethan-1-amine hydrochloride | 1087761-52-1 | Details |
4',4'-Dimethyl-3',4'-dihydro-2'H-spiro[cyclopropane-1,1'-naphthalene]-2-ylmethanamine hydrochloride | C15H22ClN | 1432679-84-9 | Details |
5-Bromo-1-methyl-4-(trifluoromethyl)-1H-pyrazole | C5H4BrF3N2 | 1783749-68-7 | Details |
7-Methylimidazo[1,5-a]pyridine-1-carboxylic acid | C9H8N2O2 | 1315362-15-2 | Details |
1,6-Naphthyridin-2-amine | C8H7N3 | 17965-81-0 | Details |
(Asp-Glu-Val-Asp)2-Rh110 | Details |
H-NAPPEPVPPPR-OH | Details |
cAMPS. TEA, Sp-isomer | C16H27N6O5PS | 93602-66-5 | Details |
Methyl 2-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | C15H20BFO4 | 1415960-53-0 | Details |
5-Methyl-2-[4-(nitrophenyl)-1,3,4-oxadiazole | C9H7N3O3 | 22815-99-2 | Details |
2-Amino-1-Boc-imidazole | C8H13N3O2 | 929568-19-4 | Details |
7,7-Difluoro-6-methyl-3-azabicyclo[4.1.0]heptane hydrochloride | C7H12ClF2N | 1803582-38-8 | Details |
Tranexamic acid-13C2,15N | C8H15NO2 | 1292837-95-6 | Details |
2-(1-Methyl-5-oxopyrrolidin-2-yl)acetic acid | C7H11NO3 | 60307-25-7 | Details |
CD43 antibody (PE) | Details |
Product Total: Product Page: | ||||
221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 |